BTG2 can inhibit tumor growth and progression in breast cancer by suppressing the tumor microenvironments by regulating the mTORc2-AKT1-NFAT1-PHLPP2 signaling cascade [63]. This evidence concerns the gene NFATC2 and neoplasm.